Purchase Order 36C26024P0722
Award Date
6/28/24
Potential Completion Date
6/27/25
Potential Value
$308K
Federal Agency
Veterans Integrated Service Network 20
Awardee
Accredo Health Group, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order award from the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Accredo Health Group, Inc., a for-profit pharmaceutical distribution company. The $38,493.36 contract is for the delivery of LUMRYZ 9GM/PKT (sodium oxybate), a specialty medication, to support the VHA's integrated healthcare networks. As a prime contractor, Accredo regularly fulfills purchase orders and multi-year contracts with the VA to supply specialty...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the supply of LUMRYZ (sodium oxybate) 6 GM/PKT, a specialty pharmaceutical product, to the VA's Veterans Integrated Service Network 9. The contract has a ceiling value of $12,222.02 and a period of performance ending on June 30, 2025. The contract was awarded on June 4, 2025, and does not have...
This is a federal contract award to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 (VISN 9). The contract has a firm fixed-price of $7,509.56 for the purchase of the specialty pharmaceutical product Lumryz. The contract is a purchase order with a performance period from the award date of December 10, 2024 to the ultimate completion date of December 11, 2024. This contract award is...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 22 (VISN 22) to Accredo Health Group, Inc., a for-profit pharmaceutical distributor. The contract, valued at $76,986.72, is for the delivery of the specialty medication "EMERGENCY LUMRYZ 9GM" with a period of performance ending on September 30, 2025. Accredo Health Group, Inc. is a subsidiary of Express Scripts and a key provider of complex and high-value...
This is a federal contract award from the Veterans Integrated Service Network 20 (VISN 20), a civilian agency, to the prime contractor Accredo Health Group, Inc. The contract is for the purchase of LUMRYX 7.5G, a pharmaceutical product, with a firm fixed price of $40,091.73 and a completion date of September 30, 2025. The contract does not have a set-aside designation. Accredo Health Group, Inc. is a for-profit pharmacy benefit management company based in Memphis, Tennessee, and a subsidiary...
This federal contract award is for the purchase of specialty medications by the U.S. Department of Veterans Affairs (VA) from Accredo Health Group, Inc., a specialty pharmacy services provider. The contract award, valued at $2,603.79, is for the delivery of specific high-value medications to VA medical centers and facilities nationwide, supporting the Veterans Health Administration's (VHA) treatment programs. The contract is a firm fixed-price purchase order with no set-aside designation....
The Department of Veterans Affairs (VA) awarded a firm fixed-price purchase order contract to Accredo Health Group, Inc., a for-profit pharmacy benefit management company specializing in specialty pharmaceutical services. The $10,708.63 contract is for the emergency purchase of sodium oxybate, a medication used to treat certain medical conditions. The contract has a completion date of March 28, 2025 and is part of the VA's Veterans Integrated Service Network 12 (VISN 12) program, which...
This is a $40,697.68 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the supply of specialty pharmaceutical products, including medications to treat pulmonary arterial hypertension, neuropathic lysosomal storage disorders, and ophthalmic disorders. The contract has an ultimate completion date of March 14, 2025 and is part of the VA's Veterans...
This is a $103,003.20 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company specializing in specialty pharmaceutical services. The contract is for the delivery of various complex and high-value medications, primarily to support the VA's Veterans Integrated Service Network (VISN) healthcare facilities. Key medications provided under this contract include drugs used to treat...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 19 (VISN 19) of the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the express delivery of second quarter pharmacy orders with a ceiling value of $86,938.57 and a completion date of July 24, 2017. Accredo Health Group, Inc. is a key distributor of complex and high-value medications, primarily serving the...